Background: Guidelines should be a catalyst toward achieving, as a universal standard, the most effective possible care. However, guidelines mainly use evidence of effectiveness as the basis for recommendations. This approach may not be the most appropriate for all healthcare settings because of differing levels of available medical and financial resources. This report from the Guidelines Committee of the World Gastroenterology Organization presents a new conceptual model of cascade colorectal cancer screening guidelines that is also evidence based but resource driven. The emphasis in this variation of the model is on colonoscopy resources at the top of the cascade for a screening goal of prevention by finding and removing the colorectal cancer precursor lesions, the adenoma, as well as early detection. This is a concept study for consideration in the development of future guidelines. Various tests can be reordered within the framework of this model. The cascade concept says, "do what you can with what you have," rather than, "do it this way or no way."

Methods: A systematic review of colorectal cancer screening was performed and an evidence-based cascade (hierarchical recommendations) developed that could apply to healthcare settings having different levels of medical (primarily colonoscopy in this version of the model) resources. A review team representing both developed and developing countries examined published data and provided expert opinion. Cascade guidelines were prepared and reviewed by the team.

Results: A set of 4 resource levels were delineated based on available data: colonoscopy, sigmoidoscopy, different sensitivity fecal occult blood tests, and recommendations for colorectal cancer screening were made based on each level, from high to low resources for average risk men and women. The major resource considered was endoscopic in this version of the model.

Conclusions: Each country, region, or healthcare setting needs to determine whether colorectal cancer screening is a legitimate consideration based on other healthcare priorities. Where there is a major burden of colorectal cancer and sufficient resources to mount a screening program, the cascade colorectal cancer screening guidelines model can assist in decisions regarding screening methods. This version is based mainly on available endoscopic resources. These guidelines are evidence based but resource driven. Each healthcare setting needs to determine its resource level as a basis for selecting the screening approach that is most applicable and therefore most likely to succeed. This concept study provides a model that can be adapted to a variety of evidence-based options with consideration of available resources. Its goal is to enhance colorectal cancer screening worldwide, especially in developing countries where the colorectal cancer incidence and mortality is rising rapidly.

Download full-text PDF

Source
http://dx.doi.org/10.1097/MCG.0b013e3182098e07DOI Listing

Publication Analysis

Top Keywords

colorectal cancer
40
cancer screening
28
cascade colorectal
12
screening guidelines
12
guidelines evidence
12
screening
11
cancer
10
guidelines
9
colorectal
9
conceptual model
8

Similar Publications

Probiotics Exert Gut Immunomodulatory Effects by Regulating the Expression of Host miRNAs.

Probiotics Antimicrob Proteins

January 2025

Department of Reproductive Medicine, The Affiliated Hospital, Southwest Medical University, Luzhou, 646000, China.

Probiotics exert a diverse range of immunomodulatory effects on the human gut immune system. These mechanisms encompass strengthening the intestinal mucosal barrier, inhibiting pathogen adhesion and colonization, stimulating immune modulation, and fostering the production of beneficial substances. As a result, probiotics hold significant potential in the prevention and treatment of various conditions, including inflammatory bowel disease and colorectal cancer.

View Article and Find Full Text PDF

Background: This study investigates the association of single nucleotide polymorphism in glutathione S transferase P1 (rs1695 and rs1138272) and phosphatase and TENsin homolog (rs701848 and rs2735343) with the risk of colorectal cancer (CRC).

Patients And Methods: In this case-control study, 250 healthy controls and 200 CRC patients were enrolled. All subjects were divided into 3 groups: healthy control, patients, and overall (control + patients).

View Article and Find Full Text PDF

Colorectal cancer (CRC) continues to be a major worldwide health issue, with elevated death rates linked to late stages of the illness. Immunotherapy has made significant progress in developing effective techniques to improve the immune system's capacity to identify and eradicate cancerous cells. This study examines the most recent advancements in CAR-T cell treatment and exosome-based immunotherapy for CRC.

View Article and Find Full Text PDF

Disrupting EDEM3-induced M2-like macrophage trafficking by glucose restriction overcomes resistance to PD-1/PD-L1 blockade.

Clin Transl Med

January 2025

Department of General Surgery (Colorectal Surgery), The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China.

Background: Immunotherapy is beneficial for some colorectal cancer (CRC) patients, but immunosuppressive networks limit its effectiveness. Cancer-associatedfibroblasts (CAFs) are significant in immune escape and resistance toimmunotherapy, emphasizing the urgent need for new treatment strategies.

Methods: Flow cytometric, Western blotting, proteomics analysis, analysis of public database data, genetically modified cell line models, T cell coculture, crystal violetstaining, ELISA, metabonomic and clinical tumour samples were conducted to assess the role of EDEM3 in immune escape and itsmolecular mechanisms.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!